ConductScience.org, home

Paper39802172

Omecamtiv mecarbil in precision-cut living heart failure slices: A story of a double-edged sword.

Amesz JH and 5 others. J Mol Cell Cardiol Plus, 2023. Cited by 8 papers, by iCite.

Cite this record

ConductScience Library. Omecamtiv mecarbil in precision-cut living heart failure slices: A story of a double-edged sword. Papers, record 39802172. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/39802172

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Omecamtiv mecarbil in precision-cut living heart failure slices: A story of a double-edged sword.
PubMed
Journal
J Mol Cell Cardiol Plus
PubMed
Year
2023
PubMed
Publication types
Journal Article
PubMed
Citations, by iCite
8
iCite
Relative citation ratio, by iCite
0.98
iCite
Revised in PubMed
2025-01-14
PubMed

Authors6

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Amesz JHJorik H
2Langmuur SJJSanne J J
3Bierhuizen MFAMark F A
4de Groot NMSNatasja M S
5Manintveld OCOlivier C
6Taverne YJHJYannick J H J

Source PubMed

Download CSV of authors

Topics0

NLM's MeSH indexing of the paper, its major topics first.

None in this release.

References37

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
130631059Long-term functional and structural preservation of precision-cut human myocardium under continuous electromechanical stimulation in vitro.Nat Commun2019https://conductscience.org/library/papers/30631059PubMed
227012405Acute Treatment With Omecamtiv Mecarbil to Increase Contractility in Acute Heart Failure: The ATOMIC-AHF Study.J Am Coll Cardiol2016https://conductscience.org/library/papers/27012405PubMed
33608112Abnormal intracellular calcium handling in myocardium from patients with end-stage heart failure.Circ Res1987https://conductscience.org/library/papers/3608112PubMed
45640345Systolic time intervals in heart failure in man.Circulation1968https://conductscience.org/library/papers/5640345PubMed
518056765Sarcomeric proteins and inherited cardiomyopathies.Cardiovasc Res2008https://conductscience.org/library/papers/18056765PubMed
64227924ATPase activity of myosin correlated with speed of muscle shortening.J Gen Physiol1967https://conductscience.org/library/papers/4227924PubMed
720498236Improvement of cardiac function by a cardiac Myosin activator in conscious dogs with systolic heart failure.Circ Heart Fail2010https://conductscience.org/library/papers/20498236PubMed
835852527Effect of Omecamtiv Mecarbil on Exercise Capacity in Chronic Heart Failure With Reduced Ejection Fraction: The METEORIC-HF Randomized Clinical Trial.JAMA2022https://conductscience.org/library/papers/35852527PubMed
926140433The novel cardiac myosin activator omecamtiv mecarbil increases the calcium sensitivity of force production in isolated cardiomyocytes and skeletal muscle fibres of the rat.Br J Pharmacol2015https://conductscience.org/library/papers/26140433PubMed
1031863532Association between systolic ejection time and outcomes in heart failure by ejection fraction.Eur J Heart Fail2020https://conductscience.org/library/papers/31863532PubMed
1127914656Chronic Oral Study of Myosin Activation to Increase Contractility in Heart Failure (COSMIC-HF): a phase 2, pharmacokinetic, randomised, placebo-controlled trial.Lancet2016https://conductscience.org/library/papers/27914656PubMed
1232231589The Degree of t-System Remodeling Predicts Negative Force-Frequency Relationship and Prolonged Relaxation Time in Failing Human Myocardium.Front Physiol2020https://conductscience.org/library/papers/32231589PubMed
1316418450Mechanisms and use of calcium-sensitizing agents in the failing heart.Circulation2006https://conductscience.org/library/papers/16418450PubMed
1435030072Comprehensive analyses of the inotropic compound omecamtiv mecarbil in rat and human cardiac preparations.Am J Physiol Heart Circ Physiol2022https://conductscience.org/library/papers/35030072PubMed
1534096321Danicamtiv Enhances Systolic Function and Frank-Starling Behavior at Minimal Diastolic Cost in Engineered Human Myocardium.J Am Heart Assoc2021https://conductscience.org/library/papers/34096321PubMed
1627322915The myosin activator omecamtiv mecarbil: a promising new inotropic agent.Can J Physiol Pharmacol2016https://conductscience.org/library/papers/27322915PubMed
1727206819
2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure: The Task Force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC)Developed with the special contribution of the Heart Failure Association (HFA) of the ESC.
Eur Heart J2016https://conductscience.org/library/papers/27206819PubMed
1817360992The failing heart--an engine out of fuel.N Engl J Med2007https://conductscience.org/library/papers/17360992PubMed
1921616079Cardiac myosin activation part 1: from concept to clinic.J Mol Cell Cardiol2011https://conductscience.org/library/papers/21616079PubMed
2029030372Dose-Dependent Effects of the Myosin Activator Omecamtiv Mecarbil on Cross-Bridge Behavior and Force Generation in Failing Human Myocardium.Circ Heart Fail2017https://conductscience.org/library/papers/29030372PubMed

See all 37 referencesDownload CSV of references

Cited by7

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 8 citations.

PMIDTitleJournalYearIn PapersSource
42126521Advances in Living Myocardial Slice Technology for Heart Failure Research.Curr Heart Fail Rep2026https://conductscience.org/library/papers/42126521PubMed
40831223Insights from electromechanical simulations to assess omecamtiv mecarbil efficacy in heart failure.J Physiol2026https://conductscience.org/library/papers/40831223PubMed
40354127Living myocardial slices: walking the path towards standardization.Cardiovasc Res2025https://conductscience.org/library/papers/40354127PubMed
40001693Acute Biomechanical Effects of Cardiac Contractility Modulation in Living Myocardial Slices from End-Stage Heart Failure Patients.Bioengineering (Basel)2025https://conductscience.org/library/papers/40001693PubMed
39802436Charting our course: Indexing milestones for JMCC PLUS.J Mol Cell Cardiol Plus2024https://conductscience.org/library/papers/39802436PubMed
39802175Myosin activator omecamtiv mecarbil exhibits divergent inotropic and lusitropic effects in cardiac slices from patients with heart failure.J Mol Cell Cardiol Plus2023https://conductscience.org/library/papers/39802175PubMed
38790961Emerging Concepts of Mechanisms Controlling Cardiac Tension: Focus on Familial Dilated Cardiomyopathy (DCM) and Sarcomere-Directed Therapies.Biomedicines2024https://conductscience.org/library/papers/38790961PubMed

Download CSV of cited by

Genes1

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

GeneNCBI Gene IDLinked byIn Genes
MYH1479784PubTator's text mininghttps://conductscience.org/library/genes/79784

Source NCBI Gene

Download CSV of genes

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/39802172

GET https://conductscience.org/api/papers/v1/39802172/references?page=2